CMS, FDA to Launch Parallel Review of New Medical Devices

The Food and Drug Administration and the Centers for Medicare & Medicaid Services, which usually conduct separate reviews of medical devices to determine safety, effectiveness, and whether they merit federal coverage, will test a parallel review process for innovative concepts.

Name:
E-mail:
Website:
Please enter your comment below:

Please enter the text below: